Development and evaluation of novel nanoparticle formulations for therapeutic genome editing
Development and evaluation of novel nanoparticle formulations for therapeutic genome editing
批准号:
477324
负责人:
Ross Colin J
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-10-01 至 2023-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Genetic diseases are a leading cause of death and disability in Canada and worldwide with immense economic and societal burdens. CRISPR has revolutionized the potential to treat these diseases; however, conventional CRISPR introduces DNA breaks and the de
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and evaluation of novel nanoparticle formulations for therapeutic genome editing
-
批准号:479068
-
项目类别:Operating Grants
-
资助金额:$71.06万
-
财政年份:2023
-
负责人:Ross Colin J
-
依托单位:
Discovery, validation, and pre-clinical development of novel strategies to prevent anthracycline-induced cardiotoxicity.
-
批准号:356014
-
项目类别:Operating Grants
-
资助金额:$41.8万
-
财政年份:2016
-
负责人:Ross Colin J
-
依托单位:
Identification of pharmacogenomic variants for the prevention of vincristine-induced neurotoxicity.
-
批准号:274153
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2012
-
负责人:Ross Colin J
-
依托单位:
Pharmacogenetics of Warfarin Safety and Effectiveness in Children.
-
批准号:244057
-
项目类别:Operating Grants
-
资助金额:$7.1万
-
财政年份:2011
-
负责人:Ross Colin J
-
依托单位:
Drug Safety Pharmacogenetics Evaluation (Drug SAPHE) Initiative
-
批准号:241769
-
项目类别:Salary Programs
-
资助金额:$21.86万
-
财政年份:2011
-
负责人:Ross Colin J
-
依托单位:
国内基金
海外基金
运用CRISPR/Base editor技术调控Ku80分子跨核转运研究hsa-miR-623抑制非小细胞肺癌转移的机制
-
批准号:81772477
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2017
-
负责人:魏双
-
依托单位: